Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

ClinicalTrials.gov ID: NCT05113953

Public ClinicalTrials.gov record NCT05113953. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 4:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets After Oral Administration in Adult Subjects With Binge Eating Disorder

Study identification

NCT ID
NCT05113953
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
147 participants

Conditions and interventions

Interventions

  • Centanafadine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2021
Primary completion
Aug 18, 2022
Completion
Aug 18, 2022
Last update posted
Sep 8, 2025

2021 – 2022

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
NoesisPharma, LLC Phoenix Arizona 85016
Southern California Research LLC Beverly Hills California 90210
Pharmacology Research Institute - San Fernando Valley Encino California 91316
Collaborative Neuroscience Research, LLC Garden Grove California 92845
Pacific Clinical Research Management Group LLC Upland California 91786
Mountain View Clinical Research, LLC Denver Colorado 80209
Clinical Neuroscience Solutions - Jacksonville Jacksonville Florida 32256
Miami Dade Medical Research Institute Miami Florida 33176
iResearch Atlanta Decatur Georgia 30030
Psych Atlanta, PC Marietta Georgia 30060
Psychiatric Associates Overland Park Kansas 66211
Collective Medical Research Prairie Village Kansas 66208
Boston Clinical Trials Boston Massachusetts 02131
St. Charles Psychiatric Associates & Midwest Research Group Weldon Spring Missouri 63304
ActivMed Practices and Research - Portsmouth Portsmouth New Hampshire 03801
Center for Emotional Fitness Cherry Hill New Jersey 08002
Princeton Medical Institute Princeton New Jersey 08540
Manhattan Behavioral Medicine New York New York 10036
Medical Research Network, LLC New York New York 10128
Richmond Behavioral Associates Staten Island New York 10312
Midwest Clinical Research Center Dayton Ohio 45417
Craig and Frances Linder Center of Hope Mason Ohio 45040
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119
Psychiatry + Psychotherapy Partners Austin Austin Texas 78737
FutureSearch Trials - Dallas Dallas Texas 75231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05113953, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2025 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05113953 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →